Neurodegenerative diseases represent a critical challenge in neuroscience, encompassing conditions like Alzheimer’s, Parkinson’s, and Huntington’s diseases. These disorders are characterized by progressive neuronal damage, leading to cognitive, motor, and functional impairments. Current research focuses on unraveling the molecular and genetic mechanisms underlying these diseases, with an emphasis on identifying early biomarkers for timely diagnosis. Advances in therapeutic approaches, such as monoclonal antibodies, RNA-based therapies, and neuroprotective strategies, aim to slow disease progression and improve quality of life. Interdisciplinary collaborations are pivotal in developing innovative interventions, fostering hope for effective solutions to these debilitating conditions.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Futurey on neurology
Luiz Moutinho, University of Suffolk, United Kingdom
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Predictors of neurological recovery following traumatic spinal cord
W S El Masri, Keele University, United Kingdom
Title : The vision neurology as bio-recursion and brain-blockchain
Dobilas Kirvelis, Lithuanian Scientific Society, Lithuania